Celcuity Inc.

NasdaqCM:CELC 株式レポート

時価総額：US$489.7m

Celcuity マネジメント

マネジメント 基準チェック /44

Celcuityの CEO はBrian Sullivanで、 Jan2012年に任命され、 の在任期間は 12.83年です。 の年間総報酬は$ 1.74Mで、 12.1%給与と87.9%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の8.12%を直接所有しており、その価値は$ 39.79M 。経営陣と取締役会の平均在任期間はそれぞれ3.8年と9.3年です。

主要情報

Brian Sullivan

最高経営責任者

US$1.7m

報酬総額

CEO給与比率12.1%
CEO在任期間12.8yrs
CEOの所有権8.1%
経営陣の平均在職期間3.8yrs
取締役会の平均在任期間9.3yrs

経営陣の近況

Recent updates

Celcuity: Breast Cancer Drug Developer With Upcoming Catalysts

Nov 06

Is Celcuity (NASDAQ:CELC) Using Too Much Debt?

Aug 31
Is Celcuity (NASDAQ:CELC) Using Too Much Debt?

Celcuity: Flying A Phase 3 Trial Right Under Your Nose

Jul 05

Does Celcuity (NASDAQ:CELC) Have A Healthy Balance Sheet?

May 08
Does Celcuity (NASDAQ:CELC) Have A Healthy Balance Sheet?

Is Celcuity (NASDAQ:CELC) Using Too Much Debt?

Jul 04
Is Celcuity (NASDAQ:CELC) Using Too Much Debt?

Is Celcuity (NASDAQ:CELC) A Risky Investment?

Sep 13
Is Celcuity (NASDAQ:CELC) A Risky Investment?

Celcuity rises after hours on FDA Breakthrough Therapy nod for its breast cancer treatment

Jul 18

Is Celcuity (NASDAQ:CELC) A Risky Investment?

Jan 27
Is Celcuity (NASDAQ:CELC) A Risky Investment?

Health Check: How Prudently Does Celcuity (NASDAQ:CELC) Use Debt?

Sep 21
Health Check: How Prudently Does Celcuity (NASDAQ:CELC) Use Debt?

Celcuity: Nipping The Oncogenic Bud

Jul 08

What You Need To Know About Celcuity Inc.'s (NASDAQ:CELC) Investor Composition

Mar 14
What You Need To Know About Celcuity Inc.'s (NASDAQ:CELC) Investor Composition

We're Hopeful That Celcuity (NASDAQ:CELC) Will Use Its Cash Wisely

Jan 20
We're Hopeful That Celcuity (NASDAQ:CELC) Will Use Its Cash Wisely

Celcuity inks clinical trial pact with Massachusetts General Hospital and Puma Technologies

Dec 23

Could The Celcuity Inc. (NASDAQ:CELC) Ownership Structure Tell Us Something Useful?

Nov 29
Could The Celcuity Inc. (NASDAQ:CELC) Ownership Structure Tell Us Something Useful?

Celcuity EPS beats by $0.03

Nov 09

CEO報酬分析

Celcuity の収益と比較して、Brian Sullivan の報酬はどのように変化したか？
日付総報酬給与会社業績
Sep 30 2024n/an/a

-US$94m

Jun 30 2024n/an/a

-US$83m

Mar 31 2024n/an/a

-US$73m

Dec 31 2023US$2mUS$210k

-US$64m

Sep 30 2023n/an/a

-US$57m

Jun 30 2023n/an/a

-US$49m

Mar 31 2023n/an/a

-US$45m

Dec 31 2022US$2mUS$106k

-US$41m

Sep 30 2022n/an/a

-US$36m

Jun 30 2022n/an/a

-US$31m

Mar 31 2022n/an/a

-US$35m

Dec 31 2021US$1mUS$260k

-US$30m

Sep 30 2021n/an/a

-US$25m

Jun 30 2021n/an/a

-US$22m

Mar 31 2021n/an/a

-US$10m

Dec 31 2020US$469kUS$250k

-US$9m

Sep 30 2020n/an/a

-US$9m

Jun 30 2020n/an/a

-US$8m

Mar 31 2020n/an/a

-US$8m

Dec 31 2019US$992kUS$250k

-US$7m

Sep 30 2019n/an/a

-US$7m

Jun 30 2019n/an/a

-US$7m

Mar 31 2019n/an/a

-US$7m

Dec 31 2018US$564kUS$250k

-US$7m

Sep 30 2018n/an/a

-US$7m

Jun 30 2018n/an/a

-US$7m

Mar 31 2018n/an/a

-US$7m

Dec 31 2017US$490kUS$232k

-US$6m

報酬と市場: Brianの 総報酬 ($USD 1.74M ) は、 US市場 ($USD 2.18M ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Brianの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Brian Sullivan (62 yo)

12.8yrs

在職期間

US$1,738,115

報酬

Mr. Brian F. Sullivan is the Co-Founder of Celcuity Inc. and has been its Chairman and Chief Executive Officer since 2012 and served as its Chief Financial Officer. Mr. Sullivan Co-founded Entegris, Inc. i...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Brian Sullivan
Co-Founder12.8yrsUS$1.74m8.12%
$ 39.8m
Lance Laing
Co-Founder12.8yrsUS$1.48m3.37%
$ 16.5m
Vicky Hahne
Chief Financial Officer7.3yrsUS$898.74k0.050%
$ 244.8k
Brent Eilefson
General Counselless than a yearデータなしデータなし
John MacDonald
Senior Vice President of R&D3.8yrsデータなしデータなし
Sheri Smith
Acting Head of Clinical Operations3.8yrsデータなしデータなし
Igor Gorbatchevsky
Chief Medical Officer2.7yrsデータなしデータなし
Eldon Mayer
Chief Commercial Officerless than a yearデータなしデータなし
Charlotte Moser
Senior Vice President of Clinical Developmentless than a yearデータなしデータなし

3.8yrs

平均在職期間

62yo

平均年齢

経験豊富な経営陣: CELCの経営陣は 経験豊富 であると考えられます ( 3.8年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Brian Sullivan
Co-Founder12.8yrsUS$1.74m8.12%
$ 39.8m
Lance Laing
Co-Founder12.8yrsUS$1.48m3.37%
$ 16.5m
Richard Nigon
Independent Director7.8yrsUS$87.50k0.27%
$ 1.3m
David Dalvey
Independent Director10.8yrsUS$87.50k0.025%
$ 123.0k
Leo Furcht
Independent Director5.5yrsUS$87.50k0.028%
$ 138.5k
Ronald McGlennen
Member of Scientific Advisory Boardno dataデータなしデータなし
Edward Greeno
Member of Scientific Advisory Boardno dataデータなしデータなし
Sara A. Hurvitz
Member of Scientific Advisory Boardno dataデータなしデータなし
Carol Lange
Member of Scientific Advisory Boardno dataデータなしデータなし
Benita Katzenellenbogen
Member of Scientific Advisory Boardno dataデータなしデータなし
John Katzenellenbogen
Member of Scientific Advisory Boardno dataデータなしデータなし
Mothaffar Rimawi
Member of Scientific Advisory Board5.8yrsデータなしデータなし

9.3yrs

平均在職期間

66yo

平均年齢

経験豊富なボード: CELCの 取締役会 は 経験豊富 であると考えられます ( 9.3年の平均在任期間)。